GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (BSP:HYPE3) » Definitions » ROE % Adjusted to Book Value

Hypera (BSP:HYPE3) ROE % Adjusted to Book Value : 2.76% (As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Hypera ROE % Adjusted to Book Value?

Hypera's ROE % for the quarter that ended in Dec. 2024 was 2.62%. Hypera's PB Ratio for the quarter that ended in Dec. 2024 was 0.95. Hypera's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 2.76%.


Hypera ROE % Adjusted to Book Value Historical Data

The historical data trend for Hypera's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera ROE % Adjusted to Book Value Chart

Hypera Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.14 7.66 6.19 7.55 11.96

Hypera Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.45 7.60 11.01 9.14 2.76

Competitive Comparison of Hypera's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Hypera's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hypera's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hypera's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Hypera's ROE % Adjusted to Book Value falls into.


;
;

Hypera ROE % Adjusted to Book Value Calculation

Hypera's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=11.36% / 0.95
=11.96%

Hypera's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=2.62% / 0.95
=2.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hypera ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Hypera's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Hypera Business Description

Industry
Traded in Other Exchanges
Address
Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.

Hypera Headlines

No Headlines